Hafrun Fridriksdottir Teva Pharmaceutical Industries LTD (TEVA) insider trading activity

TEVA Quotes by TradingView

Hafrun Fridriksdottir is Executive VP, Global R&D of TEVA PHARMACEUTICAL INDUSTRIES LTD. Currently has a direct ownership of 1,386 shares of TEVA, which is worth approximately $22,993. The most recent transaction as insider was on May 17, 2022, when has been sold 130,000 shares (Ordinary Shares) at a price of $8.22 per share, resulting in proceeds of $1,068,600. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.39K
0% 3M change
0% 12M change
Total Value Held $22,993

Hafrun Fridriksdottir Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 17 2022
SELL
Open market or private sale
$1,068,600 $8.22 p/Share
130,000 Reduced 98.95%
1,386 Ordinary Shares
Mar 07 2022
SELL
Open market or private sale
$65,895 $7.37 p/Share
8,941 Reduced 6.62%
126,086 Ordinary Shares
Mar 05 2022
BUY
Exercise of conversion of derivative security
-
23,764 Added 14.97%
135,027 Ordinary Shares
Mar 04 2022
SELL
Open market or private sale
$184,292 $7.48 p/Share
24,638 Reduced 18.13%
111,263 Ordinary Shares
Mar 04 2022
BUY
Exercise of conversion of derivative security
-
70,393 Added 37.39%
117,881 Ordinary Shares
Feb 28 2022
SELL
Open market or private sale
$61,783 $8.14 p/Share
7,590 Reduced 10.38%
65,508 Ordinary Shares
Feb 28 2022
BUY
Exercise of conversion of derivative security
-
21,682 Added 22.88%
73,098 Ordinary Shares
Feb 09 2022
SELL
Open market or private sale
$55,411 $9.06 p/Share
6,116 Reduced 10.63%
51,416 Ordinary Shares
Feb 09 2022
BUY
Exercise of conversion of derivative security
-
16,121 Added 21.89%
57,532 Ordinary Shares
Aug 10 2021
SELL
Open market or private sale
$506,057 $9.95 p/Share
50,860 Reduced 55.12%
41,411 Ordinary Shares
May 11 2021
SELL
Open market or private sale
$194,855 $10.22 p/Share
19,066 Reduced 17.12%
92,271 Ordinary Shares
May 11 2021
BUY
Exercise of conversion of derivative security
-
37,884 Added 25.39%
111,337 Ordinary Shares
Mar 04 2021
SELL
Open market or private sale
$100,574 $10.57 p/Share
9,515 Reduced 11.47%
73,453 Ordinary Shares
Mar 04 2021
BUY
Exercise of conversion of derivative security
-
18,905 Added 18.56%
82,968 Ordinary Shares
Mar 02 2021
SELL
Open market or private sale
$541,000 $10.82 p/Share
50,000 Reduced 43.84%
64,063 Ordinary Shares
Mar 01 2021
SELL
Open market or private sale
$118,177 $10.83 p/Share
10,912 Reduced 8.73%
114,063 Ordinary Shares
Feb 28 2021
BUY
Exercise of conversion of derivative security
-
21,682 Added 14.78%
124,975 Ordinary Shares
Feb 16 2021
SELL
Open market or private sale
$23,330 $11.12 p/Share
2,098 Reduced 1.99%
103,293 Ordinary Shares
Feb 14 2021
BUY
Exercise of conversion of derivative security
-
5,355 Added 4.84%
105,391 Ordinary Shares
Feb 09 2021
SELL
Open market or private sale
$374,304 $12.69 p/Share
29,496 Reduced 22.77%
100,036 Ordinary Shares
Feb 09 2021
BUY
Grant, award, or other acquisition
-
67,852 Added 34.38%
129,532 Ordinary Shares
Feb 09 2021
BUY
Exercise of conversion of derivative security
-
16,120 Added 20.72%
61,680 Ordinary Shares
HF

Hafrun Fridriksdottir

Executive VP, Global R&D
Tel Aviv, L3

Track Institutional and Insider Activities on TEVA

Follow TEVA PHARMACEUTICAL INDUSTRIES LTD and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TEVA shares.

Notify only if

Insider Trading

Get notified when an Teva Pharmaceutical Industries LTD insider buys or sells TEVA shares.

Notify only if

News

Receive news related to TEVA PHARMACEUTICAL INDUSTRIES LTD

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on TEVA